http://www.unboundmedicine.com/medline/ebm/research/ActiqUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/18454617/full_citation/Oral_Transmucosal_Fentanyl_Citrate_OTFC__ACTIQ____#103_Gordon D, Schroeder M 
Oral Transmucosal Fentanyl Citrate-OTFC (ACTIQ()) #103. [Journal Article]
J Palliat Med 2008 May; 11(4):633-4.
Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18298711/full_citation/Is_actiq_use_in_noncancer_related_pain_really_"a_recipe_for_success"O'Connor AB 
Is actiq use in noncancer-related pain really "a recipe for success"? [Journal Article]
Pain Med 2008 Mar; 9(2):258-60.
Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/17851376/full_citation/Treating_cancer_related_breakthrough_pain:_the_oral_transmucosal_route_Laverty D 
Treating cancer-related breakthrough pain: the oral transmucosal route. [Journal Article]
Int J Palliat Nurs 2007 Jul; 13(7):326-31.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/17851311/full_citation/Actiq:_an_effective_oral_treatment_for_cancer_related_breakthrough_pain_Laverty D 
Actiq: an effective oral treatment for cancer-related breakthrough pain. [Journal Article]
Br J Community Nurs 2007 Jul; 12(7):311-6.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/17722512/full_citation/Oral_transmucosal_fentanyl_citrate_in_cancer_pain_management:_a_practical_application_of_nanotechnology_Mystakidou K, Tsilika E, Tsiatas M, et al. 
Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology. [Journal Article]
Int J Nanomedicine 2007; 2(1):49-54.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/17371416/full_citation/Impact_of_Breakthrough_Pain_on_Quality_of_Life_in_Patients_with_Chronic_Noncancer_Pain:_Patient_Perceptions_and_Effect_of_Treatment_with_Oral_Transmucosal_Fentanyl_Citrate__OTFC_ACTIQ__Taylor DR, Webster LR, Chun SY, et al. 
Impact of Breakthrough Pain on Quality of Life in Patients with Chronic, Noncancer Pain: Patient Perceptions and Effect of Treatment with Oral Transmucosal Fentanyl Citrate (OTFC, ACTIQ). [Journal Article]
Pain Med 2007 May-Jun; 8(3):281-8.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/17315410/full_citation/Oral_transmucosal_fentanyl_citrate_for_the_treatment_of_breakthrough_pain_in_cancer_patients:_an_overview_of_its_pharmacological_and_clinical_characteristics_Mystakidou K, Katsouda E, Parpa E, et al. 
Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics. [Journal Article]
J Opioid Manag 2005 Mar-Apr; 1(1):36-40.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/17305684/full_citation/Weighing_in_on_the_Off_Label_Use_of_Actiqtrade_mark_for_Noncancer_Related_Pain:_A_Recipe_for_Success_or_a_Recipe_for_DisasterPassik SD, Kirsh KL 
Weighing in on the Off-Label Use of Actiqtrade mark for Noncancer-Related Pain: A Recipe for Success or a Recipe for Disaster? [Journal Article]
Pain Med 2007 Mar-Apr; 8(2):130-3.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/16766468/full_citation/Oral_transmucosal_fentanyl_citrate:_overview_of_pharmacological_and_clinical_characteristics_Mystakidou K, Katsouda E, Parpa E, et al. 
Oral transmucosal fentanyl citrate: overview of pharmacological and clinical characteristics. [Journal Article]
Drug Deliv 2006 Jul-Aug; 13(4):269-76.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/15909786/full_citation/Oral_transmucosal_fentanyl_citrate_for_the_treatment_of_breakthrough_pain_in_cancer_patients:_an_overview_of_its_pharmacological_and_clinical_characteristics_Mystakidou K, Katsouda E, Parpa E, et al. 
Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics. [Journal Article, Review]
Am J Hosp Palliat Care 2005 May-Jun; 22(3):228-32.
Abstract | Full Citation | Find Related Articles